The pharmaceutical equipment industry is facing a new change!

With the acceleration of the construction of vaccine companies and the rapid development of the biomedical industry, the market demand for the pharmaceutical equipment industry continues to expand, and at the same time domestic substitution accelerates, bringing greater development opportunities to the domestic pharmaceutical machine industry
.
Today, standing at a new starting point in 2022, the boom and changes of the pharmaceutical equipment industry have attracted much attention from the industry
.
The pharmaceutical equipment industry is facing a new change! (Image source: Pharmaceutical Network) The organization also pays great attention to the situation of the pharmaceutical equipment industry.
At the end of 2021, a series of intensive investigations were carried out on representative domestic pharmaceutical giants
.
On December 31, 2021, Chutian Technology issued an announcement stating that a total of 8 institutions will investigate the company on December 30
.
Among them, in response to the issue of industry prosperity, which is concerned by the organization, the company said that the normalization of GMP certification has given time and space to the release of production capacity in the upstream pharmaceutical equipment industry
.
At the same time, global innovative drugs and biological drugs are booming, and there is a great demand for high-level and high-quality medical equipment
.
It is worth mentioning that Chutian Technology also proposed that a new change it is now facing is the increase in industry concentration, whether it is the pharmaceutical industry or the pharmaceutical equipment industry
.
In order to enhance market competitiveness, companies have higher requirements for product technology and manufacturing technology investment, which is more beneficial to leading companies in the industry
.
At present, the market concentration of China's pharmaceutical equipment industry is indeed relatively low.
It is mainly dominated by the two local pharmaceutical giants Chutian Technology and Tofflon, followed by Austar Life Technology, Xinhua Medical, and Canaan.
Technology, Tai Lin biology
.
According to financial data, in 2020, the operating income of the two companies, Tofflon and Chutian Technology, will be 2.
18 billion yuan and 2.
02 billion yuan, respectively.
It is estimated that the market size of pharmaceutical equipment, process systems and services in that year is about 100 billion yuan.
The market share of Dongfulong and Chutian Technology is only 4%.
From the data, it can be seen that the market concentration is not high
.
In addition to giant companies, domestic pharmaceutical machinery companies are mostly small and medium-sized companies
.
From the perspective of the regional distribution of the pharmaceutical equipment industry, relevant data collection information shows that as of December 2021, major domestic pharmaceutical equipment companies are concentrated in Shandong, Jiangsu, Hebei, Shanghai, Zhejiang, Guangdong and other coastal and northern regions
.
Among them, the number of pharmaceutical machinery companies in coastal areas is relatively large.
For example, the number of pharmaceutical equipment companies in Shandong Province has exceeded 1,300, followed by Jiangsu Province, and the number of manufacturers is also increasing towards the target of 1,000.
The number accounts for more than half of the total number of pharmaceutical equipment companies in the country
.
The analysis believes that due to the late start of the domestic pharmaceutical equipment industry, it is still in the stage of breakthrough development.
Relatively speaking, the overseas market is relatively mature
.
However, in recent years, local companies, represented by domestic pharmaceutical giants, have also been cultivating both domestic and international markets, inferring that the industry concentration is expected to further increase in the future
.
For example, in the domestic market, by strengthening the construction of the domestic distribution network and establishing a professional distribution team, some companies have accumulated a large number of customer resources and industry solutions.
With the further development of the domestic pharmaceutical market, their customer base has a coverage area It is expected to continue to expand and further increase the market concentration; in overseas markets, including Chutian Technology and Dongfulong, they are also actively recruiting talents since the end of 2021, aiming to serve international business development, improve international service levels, and further stabilize Increase international market share
.